يعرض 1 - 10 نتائج من 12 نتيجة بحث عن '"PHENOMENA AND PROCESSES::Genetic Phenomena::Gene Expression Regulation::Epigenesis"', وقت الاستعلام: 1.05s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Boronat-Toscano A, Vañó I, Monfort-Ferré D Hospital Universitari de Tarragona Joan XXIII, Institut d’Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Tarragona, Spain. Menacho M, Valldosera G Digestive Unit, Hospital Universitari Joan XXIII, Tarragona, Spain. Caro A Colorectal Surgery Unit, Hospital Universitari Joan XXIII, Tarragona, Spain. Marti M, Espin E Unitat de Cirurgia de Còlon i Recte, Servi de Cirurgia General i Digestiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cells;12(7); https://doi.org/10.3390/cells12071021Test; Boronat-Toscano A, Vañó I, Monfort-Ferré D, Menacho M, Valldosera G, Caro A, et al. Smoking Suppresses the Therapeutic Potential of Adipose Stem Cells in Crohn’s Disease Patients through Epigenetic Changes. Cells. 2023 Mar 27;12(7):1021.; https://hdl.handle.net/11351/9456Test

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Gallardo VJ, Vila-Pueyo M Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Pozo-Rosich P Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat de Cefalees, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cephalalgia;43(2); https://doi.org/10.1177/03331024221145916Test; info:eu-repo/grantAgreement/EC/H2020/101023175; Gallardo VJ, Vila-Pueyo M, Pozo-Rosich P. The impact of epigenetic mechanisms in migraine: Current knowledge and future directions. Cephalalgia. 2023 Feb;43(2):1–12.; https://hdl.handle.net/11351/9904Test; 000931410500007

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Sayago C, Sánchez-Wandelmer J, García F Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Hurtado B Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Cancer Cell Cycle group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Lafarga V Genomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Prieto P Mouse Genome Editing Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Nature Communications;14; https://doi.org/10.1038/s41467-023-38863-1Test; info:eu-repo/grantAgreement/EC/H2020/823839; Sayago C, Sánchez-Wandelmer J, García F, Hurtado B, Lafarga V, Prieto P, et al. Decoding protein methylation function with thermal stability analysis. Nat Commun. 2023 May 25;14:3016.; https://hdl.handle.net/11351/9794Test

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Vezzoli M, Morselli M, Montanini B Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy. de Llobet Cucalon LI Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Di Vona C Genome Biology Program, Center for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST) and Universitat Pompeu Fabra (UPF), Barcelona, Spain. CIBER of Rare Diseases (CIBERER), Barcelona, Spain. de la Luna S Genome Biology Program, Center for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST) and Universitat Pompeu Fabra (UPF), Barcelona, Spain. CIBER of Rare Diseases (CIBERER), Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: International Journal of Molecular Sciences;24(4); https://doi.org/10.3390/ijms24043624Test; Vezzoli M, de Llobet Cucalon LI, Di Vona C, Morselli M, Montanini B, de la Luna S, et al. TFIIIC as a Potential Epigenetic Modulator of Histone Acetylation in Human Stem Cells. Int J Mol Sci. 2023 Feb 11;24(4):3624.; https://hdl.handle.net/11351/9149Test

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Godoy-Tena G, Morante-Palacios O, de la Calle-Fabregat C, Martins-Ferreira R, Ferreté-Bonastre AG Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain. Barmada A Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. Department of Medical Genetics, University of Cambridge, Cambridge, UK. Ruiz-Sanmartín A, Ferrer R, Ruiz-Rodriguez JC Servei de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Shock, Disfunció Orgànica i Ressuscitació, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Martínez-Gallo M Servei d’Immunologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Immunologia Diagnòstica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Genome Medicine;14; https://doi.org/10.1186/s13073-022-01137-4Test; info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F00346; Godoy-Tena G, Barmada A, Morante-Palacios O, de la Calle-Fabregat C, Martins-Ferreira R, Ferreté-Bonastre AG, et al. Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines. Genome Med. 2022 Nov 29;14:134.; https://hdl.handle.net/11351/8611Test

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Luk IY, Tse JWT Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia. La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia. Department of Medicine, University of Melbourne, Melbourne, VIC, Australia. Jenkins LJ, Schoffer KL, Ng I Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia. La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia. Mouradov D Personalised Oncology Division, The Walter and Eliza Hall Institute of Medial Research, Parkville, VIC, Australia. Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia. Arango D Grup de Recerca Biomèdica en Tumors de l'Aparell Digestiu, CIBBIM-Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Group of Molecular Oncology, Biomedical Research institute of Lleida (IRBLleida), Lleida, Spain. Dopeso H Grup de Recerca Biomèdica en Tumors de l'Aparell Digestiu, CIBBIM-Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cell Death & Differentiation;29; https://doi.org/10.1038/s41418-022-01016-wTest; Luk IY, Jenkins LJ, Schoffer KL, Ng I, Tse JWT, Mouradov D, et al. Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression. Cell Death Differ. 2022 Nov;29:2288–02.; https://hdl.handle.net/11351/8392Test; 000800969900001

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Ariceta G Servei de Nefrologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Barrios K, Brown BD, Rosskamp R Dicerna Pharmaceuticals, Inc., Lexington, Massachusetts, USA. Hoppe B Dicerna Pharmaceuticals, Inc., Lexington, Massachusetts, USA. German Hyperoxaluria Center Cologne/Bonn, Bonn, Germany. Langman CB Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Kidney International Reports;6(4); https://doi.org/10.1016/j.ekir.2021.01.029Test; Ariceta G, Barrios K, Brown BD, Hoppe B, Rosskamp R, Langman CB. Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria. Kidney Int Reports. 2021 Apr;6(4):1088–98.; https://hdl.handle.net/11351/6691Test; 000639562600025

  8. 8
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Aubets E, Ciudad CJ, Noé V Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Nanoscience and Nanotechnology Institute, IN2UB, University of Barcelona, 08028 Barcelona, Spain. Chillon M ICREA, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: International Journal of Molecular Sciences;22(18); https://doi.org/10.3390/ijms221810025Test; info:eu-repo/grantAgreement/ES/PE2017-2020/RTI2018-093901-B-I00; Aubets E, Chillon M, Ciudad CJ, Noé V. PolyPurine Reverse Hoogsteen Hairpins Work as RNA Species for Gene Silencing. Int J Mol Sci. 2021 Sep;22(18):10025.; https://hdl.handle.net/11351/7395Test; 000700750700001

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Jiménez C, Antonelli R, Masanas M, Soriano A, Magdaleno A, Jubierre L, Roma J, Segura MF Recerca Translacional en Càncer en la Infància i l’Adolescència, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Devis-Jauregui L Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. Camacho J Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Guillén G Recerca Translacional en Càncer en la Infància i l’Adolescència, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Cirurgia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Hladun R, Moreno L, Gallego S Recerca Translacional en Càncer en la Infància i l’Adolescència, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei d’Oncologia i Hematologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Sánchez de Toledo J Recerca Translacional en Càncer en la Infància i l’Adolescència, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cancers;13(19); https://doi.org/10.3390/cancers13194845Test; info:eu-repo/grantAgreement/ES/PE2013-2016/PI17%2F00564; info:eu-repo/grantAgreement/ES/PE2017-2020/PI20%2F00530; Jiménez C, Antonelli R, Masanas M, Soriano A, Devis-Jauregui L, Camacho J, et al. Neuronal Differentiation-Related Epigenetic Regulator ZRF1 Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro. Cancers. 2021 Sep 28;13(19):4845.; https://hdl.handle.net/11351/7479Test; 000708054600001

  10. 10
    دورية أكاديمية

    المساهمون: Ribeiro ML Laboratory of Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University Medical School, Braganca Paulista, Brazil. Reyes-Garau D, Armengol D, Fernández-Serrano M, Roué G Laboratory of Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Genetics;10; https://www.frontiersin.org/articles/10.3389/fgene.2019.00986/fullTest; info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F00102; info:eu-repo/grantAgreement/ES/PE2017-2020/PI18%2F01383; Ribeiro ML, Reyes-Garau D, Armengol M, Fernández-Serrano M, Roué G. Recent advances in the targeting of epigenetic regulators in b-cell non-Hodgkin lymphoma. Front Genet. 2019 Oct 16;10:986.; https://hdl.handle.net/11351/5256Test; 000497436600001